[Chine] Fosun Pharma, BioNTech see start of coronavirus vaccine trial in China an important step before securing marketing approval
– 144 participants in mainland China will receive two shots of the BNT162b1 coronavirus vaccine candidate spaced by 21 days
– BioNTech among the first international biopharmaceutical companies to start clinical trial of a Covid-19 vaccine candidate in China















